124 related articles for article (PubMed ID: 6586256)
1. Control of burn wound infections by pefloxacin and its silver derivative.
Modak S; Stanford J; Friedlaender J; Fox P; Fox CL
Burns Incl Therm Inj; 1984 Feb; 10(3):170-8. PubMed ID: 6586256
[TBL] [Abstract][Full Text] [Related]
2. Sulfadiazine silver-resistant Pseudomonas in Burns. New topical agents.
Modak SM; Fox CL
Arch Surg; 1981 Jul; 116(7):854-7. PubMed ID: 6455105
[TBL] [Abstract][Full Text] [Related]
3. Combined topical use of silver sulfadiazine and antibiotics as a possible solution to bacterial resistance in burn wounds.
Modak SM; Sampath L; Fox CL
J Burn Care Rehabil; 1988; 9(4):359-63. PubMed ID: 3146573
[TBL] [Abstract][Full Text] [Related]
4. Zinc sulfadiazine for topical therapy of pseudomonas infection in burns.
Fox CL; Modak SM; Stanford JW
Surg Gynecol Obstet; 1976 Apr; 142(4):553-9. PubMed ID: 816019
[TBL] [Abstract][Full Text] [Related]
5. Synergistic action of silver sulfadiazine and sodium piperacillin on resistant Pseudomonas aeruginosa in vitro and in experimental burn wound infections.
Modak S; Fox CL
J Trauma; 1985 Jan; 25(1):27-31. PubMed ID: 3917512
[TBL] [Abstract][Full Text] [Related]
6. Combined use of topical cyclosporin A and silver sulphadiazine on allografts infected with Pseudomonas in burned rats.
Lai CS; Miskell P; Gonce SJ; Alexander JW; Babcock GF
Burns Incl Therm Inj; 1987 Jun; 13(3):181-4. PubMed ID: 3111646
[TBL] [Abstract][Full Text] [Related]
7. Assessment of the effectiveness of silver-coated dressing, chlorhexidine acetate (0.5%), citric acid (3%), and silver sulfadiazine (1%) for topical antibacterial effects against the multi-drug resistant Pseudomonas aeruginosa infecting full-skin thickness burn wounds on rats.
Yabanoglu H; Basaran O; Aydogan C; Azap OK; Karakayali F; Moray G
Int Surg; 2013; 98(4):416-23. PubMed ID: 24229034
[TBL] [Abstract][Full Text] [Related]
8. Comparison of standard and chlorhexidine-derivative topical antibacterial agents on the infected burned rat wound.
Snelling CF; Roberts FJ; Germann E; Gillespie K; Coderre S; Henry D
Burns Incl Therm Inj; 1988 Apr; 14(2):91-100. PubMed ID: 3134114
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of supraeschar and subeschar Pseudomonas infection by silver sulfadiazine dry foam.
Catania PN; King JC
J Pharm Sci; 1975 Mar; 64(3):457-8. PubMed ID: 807702
[TBL] [Abstract][Full Text] [Related]
10. Comparative evaluation of zinc sulfadiazine and silver sulfadiazine in burn wound infection.
Fox CL; Rao TN; Azmeth R; Gandhi SS; Modak S
J Burn Care Rehabil; 1990; 11(2):112-7. PubMed ID: 2335547
[TBL] [Abstract][Full Text] [Related]
11. Silver sulfadiazine--a new topical therapy for Pseudomonas in burns. Therapy of Pseudomonas infection in burns.
Fox CL
Arch Surg; 1968 Feb; 96(2):184-8. PubMed ID: 5638080
[No Abstract] [Full Text] [Related]
12. Comparison of silver-coated dressing (Acticoat), chlorhexidine acetate 0.5% (Bactigrass), and silver sulfadiazine 1% (Silverdin) for topical antibacterial effect in Pseudomonas aeruginosa-contaminated, full-skin thickness burn wounds in rats.
Ulkür E; Oncül O; Karagöz H; Celiköz B; Cavuşlu S
J Burn Care Rehabil; 2005; 26(5):430-3. PubMed ID: 16151289
[TBL] [Abstract][Full Text] [Related]
13. Topical therapy and the development of silver sulfadiazine.
Fox CL
Surg Gynecol Obstet; 1983 Jul; 157(1):82-8. PubMed ID: 6857475
[TBL] [Abstract][Full Text] [Related]
14. Comparison of silver sulfadiazine and gentamicin for topical prophylaxis against burn wound sepsis.
Snelling CF; Ronald AR; Waters WR; Yaworski DS; Drulak K; Sunderland M
Can Med Assoc J; 1978 Sep; 119(5):466-70. PubMed ID: 99223
[TBL] [Abstract][Full Text] [Related]
15. Comparison of 1% silver sulfadiazine with and without 1% chlorhexidine digluconate for topical antibacterial effect in the burnt infected rat.
Snelling CF; Roberts FJ
J Burn Care Rehabil; 1988; 9(1):35-40. PubMed ID: 3128553
[TBL] [Abstract][Full Text] [Related]
16. Silver sulfadiazine: an antibacterial agent for topical use in burns. A review of the literature.
Hoffmann S
Scand J Plast Reconstr Surg; 1984; 18(1):119-26. PubMed ID: 6377481
[TBL] [Abstract][Full Text] [Related]
17. Activities of pefloxacin and ciprofloxacin in experimentally induced Pseudomonas pneumonia in neutropenic guinea pigs.
Gordin FM; Hackbarth CJ; Scott KG; Sande MA
Antimicrob Agents Chemother; 1985 Apr; 27(4):452-4. PubMed ID: 3159336
[TBL] [Abstract][Full Text] [Related]
18. Orally-administered silver sulfadiazine: chemotherapy and toxicology in CF-1 mice; Plasmodium berghei (Malaria) and Pseudomonas aeruginosa.
Wysor MS
Chemotherapy; 1975; 21(5):302-10. PubMed ID: 807459
[TBL] [Abstract][Full Text] [Related]
19. Clinical experience with silver sulfadiazine, a new topical agent for control of pseudomonas infections in burns.
Stanford W; Rappole BW; Fox CL
J Trauma; 1969 May; 9(5):377-88. PubMed ID: 5771755
[No Abstract] [Full Text] [Related]
20. The preparation and invivo use of silver sulphadiazine cream for treatment of burns infected with Pseudomonas aeruginosa.
Drake DJ; Froese EH
Cent Afr J Med; 1975 Apr; 21(4):71-2. PubMed ID: 806345
[No Abstract] [Full Text] [Related]
[Next] [New Search]
